| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Repare Therapeutics Inc. (RPTX) has 6 insiders with recent SEC Form 4 filings, including 20 buys and 15 sells. RPTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 0 | - | - | |
| VP | 0 | - | - | |
| Dir | 0 | - | - | |
| CFO | 0 | - | - | |
| Dir | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 27, 2024 | Koehler Maria82 | EVP, Chief Medical Officer | Sell | 1,500 | $4.67 | $7,000.00 | -0.2% | -27.0% | -77.1% | |
| Mar 27, 2024 | Segal Lloyd Mitchell85 | President And CEO | Sell | 7,950 | $4.69 | $37,259.00 | -3.0% | -27.0% | -77.1% | |
| Nov 16, 2023 | Bvf Partners L P/il60 | 10% Owner | Buy | 1,227,301 | $5.09 | $6,249,889.20 | +6.5% | +22.5% | -44.1% | |
| Nov 2, 2023 | Bvf Partners L P/il60 | 10% Owner | Buy | 783,709 | $3.60 | $2,821,352.40 | +9.6% | +80.7% | -1.1% | |
| Jun 8, 2023 | Zinda Michael85 | EVP, Chief Scientific Officer | Sell | 9,273 | $12.03 | $111,525.50 | -7.0% | -21.3% | -67.4% | |
| Jun 6, 2023 | Zinda Michael85 | EVP, Chief Scientific Officer | Sell | 1,200 | $12.04 | $14,448.00 | -1.7% | -18.1% | -65.5% | |
| Dec 9, 2022 | Jerel Davis51 | Director | Sell | 250,000 | $16.00 | $4,000,000.00 | -10.7% | -34.7% | -59.6% | |
| Jun 13, 2022 | Bvf Partners L P/il60 | 10% Owner | Buy | 149,161 | $12.73 | $1,898,819.53 | +1.9% | -0.6% | -8.2% | |
| Jun 6, 2022 | Bvf Partners L P/il60 | 10% Owner | Buy | 1,775,802 | $11.91 | $21,144,879.69 | +8.4% | -15.0% | -17.4% | |
| Jun 3, 2022 | Versant Vantage I, L.P. | 10% Owner | Sell | 750,000 | $12.25 | $9,188,775.00 | -15.7% | -4.4% | -13.0% |